Paired Box Transcription Factors
"Paired Box Transcription Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A family of transcription factors that control EMBRYONIC DEVELOPMENT within a variety of cell lineages. They are characterized by a highly conserved paired DNA-binding domain that was first identified in DROSOPHILA segmentation genes.
| Descriptor ID |
D051761
|
| MeSH Number(s) |
D12.776.260.645 D12.776.930.700
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Paired Box Transcription Factors".
Below are MeSH descriptors whose meaning is more specific than "Paired Box Transcription Factors".
This graph shows the total number of publications written about "Paired Box Transcription Factors" by people in this website by year, and whether "Paired Box Transcription Factors" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 0 | 2 | 2 |
| 1997 | 0 | 2 | 2 |
| 1998 | 0 | 3 | 3 |
| 1999 | 0 | 11 | 11 |
| 2000 | 0 | 8 | 8 |
| 2001 | 0 | 9 | 9 |
| 2002 | 0 | 9 | 9 |
| 2003 | 0 | 6 | 6 |
| 2004 | 0 | 9 | 9 |
| 2005 | 3 | 5 | 8 |
| 2006 | 6 | 3 | 9 |
| 2007 | 7 | 1 | 8 |
| 2008 | 6 | 6 | 12 |
| 2009 | 6 | 4 | 10 |
| 2010 | 6 | 7 | 13 |
| 2011 | 2 | 5 | 7 |
| 2012 | 5 | 7 | 12 |
| 2013 | 3 | 5 | 8 |
| 2014 | 4 | 11 | 15 |
| 2015 | 3 | 5 | 8 |
| 2016 | 0 | 2 | 2 |
| 2018 | 1 | 1 | 2 |
| 2019 | 1 | 1 | 2 |
| 2020 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 2 | 2 |
Below are the most recent publications written about "Paired Box Transcription Factors" by people in Profiles.
-
A conserved molecular logic for neurogenesis to gliogenesis switch in the cerebral cortex. Proc Natl Acad Sci U S A. 2024 May 14; 121(20):e2321711121.
-
Methylation markers for anal cancer screening: A repeated cross-sectional analysis of people living with HIV, 2015-2016. Int J Cancer. 2024 Sep 15; 155(6):1091-1100.
-
Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group. Clin Cancer Res. 2023 01 17; 29(2):364-378.
-
Survival outcomes of patients with localized FOXO1 fusion-positive rhabdomyosarcoma treated on recent clinical trials: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Cancer. 2021 03 15; 127(6):946-956.
-
The effects of microenergy acoustic pulses on animal model of obesity-associated stress urinary incontinence. Part 2: In situ activation of pelvic floor and urethral striated muscle progenitor cells. Neurourol Urodyn. 2019 11; 38(8):2140-2150.
-
Relationship of DNA methylation to mutational changes and transcriptional organization in fusion-positive and fusion-negative rhabdomyosarcoma. Int J Cancer. 2019 06 01; 144(11):2707-2717.
-
The HDAC3-SMARCA4-miR-27a axis promotes expression of the PAX3:FOXO1 fusion oncogene in rhabdomyosarcoma. Sci Signal. 2018 11 20; 11(557).
-
Clinical and mutational spectrum of highly differentiated, paired box 3:forkhead box protein o1 fusion-negative rhabdomyosarcoma: A report from the Children's Oncology Group. Cancer. 2018 05 01; 124(9):1973-1981.
-
SIRT1 may play a crucial role in overload-induced hypertrophy of skeletal muscle. J Physiol. 2017 06 01; 595(11):3361-3376.
-
Myofibril breakdown during atrophy is a delayed response requiring the transcription factor PAX4 and desmin depolymerization. Proc Natl Acad Sci U S A. 2017 02 21; 114(8):E1375-E1384.